CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog & Media
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • Immunotherapy Approvals in 2015

    In 2015, the FDA approved more immunotherapies than in any prior year.

    December 24, 2015| Alexandra Mulvey
  • First Monoclonal Antibody for Multiple Myeloma Receives FDA Approval

    Daratumumab (Darzalex®) is the first approved immunotherapy that targets CD38—a protein found in most multiple myeloma cells.

    November 20, 2015| Alexandra Mulvey
  • CRI Awards $29.3 Million to Fund Immunotherapies for All Kinds of Cancer

    CRI committed new funds to accelerate research and clinical development.

    August 6, 2015| Alexandra Mulvey
  • CRI Member to Chair Immuno-Oncology 360 Conference

    Dr. Axel Hoos, a member of the CRI Scientific Advisory Council, will chair and be the keynote…

    June 17, 2015| Alexandra Mulvey
  • CRI Scientists Honored With Five AACR Awards

    Carl June, Elizabeth Jaffee, James Allison, David Baltimore, and Owen Witte pick up prestigious cancer awards.

    March 16, 2015| Alexandra Mulvey
  • CRI’s Impact on Colorectal Cancer Immunotherapy

    CRI scientists have contributed significantly to the immunological understanding and treatment of colorectal cancer.

    February 26, 2015| Alexandra Mulvey
  • Immune Checkpoint Inhibitors: What’s Next?

    What’s ahead beyond CTLA-4 and PD-1?

    February 9, 2015| Alexandra Mulvey
  • World Cancer Day: The Many Languages of Cure

    From Bengali to Ukrainian, our scientists have one goal: to find a cure for all cancers within…

    February 2, 2015| Alexandra Mulvey
  • What’s in a Name?

    Cancer immunotherapies can have some mind-boggling names. But there’s a reason for it all.

    January 28, 2015| Alexandra Mulvey
CRI Logo

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog & Media
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute